Verastem (VSTM) Notes Payables (2019 - 2026)

Verastem's (VSTM) quarterly Notes Payables came in at $529000.0 in Q1 2026, down 28.51% year-on-year from $740000.0 in Q1 2025, and up 181.38% quarter-over-quarter from $188000.0 in Q3 2025.

Verastem (VSTM) Notes Payables (2019 - 2026) Analysis & Trends

Verastem's Notes Payables history runs 6 years deep, the most recent figure standing at $529000.0 for Q1 2026.

  • On a quarterly basis, Notes Payables fell 28.51% year-over-year to $529000.0 in Q1 2026; TTM through Mar 2026 was $529000.0, a 28.51% decrease from a year earlier, with the FY2022 full-year figure at $275000.0, changed N/A from the prior year.
  • Notes Payables climbed to $529000.0 in Q1 2026 per VSTM's latest filing, from $188000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $1.0 million in Q1 2023 and bottomed at $133000.0 in Q3 2024.
  • The 5-year median for Notes Payables is $526000.0 (2024), against an average of $499818.2.
  • Across the five-year window, Notes Payables soared 41.35% in 2025 and decreased 28.51% in 2026, its largest moves.
  • Year by year, Notes Payables stood at $275000.0 in 2022, then plunged by 46.91% to $146000.0 in 2023, then slipped by 8.9% to $133000.0 in 2024, then surged by 41.35% to $188000.0 in 2025, then jumped by 181.38% to $529000.0 in 2026.
  • Per Business Quant, the three latest VSTM Notes Payables figures stand at $529000.0 (Q1 2026), $188000.0 (Q3 2025), and $467000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Verastem 166.09 Mn -31.73 Mn 15.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 529,000.00
Sep 30, 2025 188,000.00
Jun 30, 2025 467,000.00
Mar 31, 2025 740,000.00
Sep 30, 2024 133,000.00
Jun 30, 2024 526,000.00
Mar 31, 2024 911,000.00
Sep 30, 2023 146,000.00
Jun 30, 2023 579,000.00
Mar 31, 2023 1.00 Mn
Dec 31, 2022 275,000.00
Dec 31, 2019 450,000.00